OCMI
Oaktop Capital Management II Portfolio holdings
AUM
$930M
This Quarter Return
+19.06%
1 Year Return
+12.03%
3 Year Return
+128.14%
5 Year Return
+269.31%
10 Year Return
+745.39%
AUM
$648M
AUM Growth
+$648M
(+14%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
93.08%
Holding
19
New
–
Increased
–
Reduced
2
Closed
3
Top Buys
No buys this quarter
Top Sells
1 |
Lam Research
LRCX
|
$12.6M |
2 |
PetMed Express
PETS
|
$1.41M |
3 |
AXDX
Accelerate Diagnostics
AXDX
|
$1.18M |
4 |
Anika Therapeutics
ANIK
|
$566K |
5 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$487K |
Sector Composition
1 | Technology | 71.13% |
2 | Industrials | 9.22% |
3 | Healthcare | 8.43% |